Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 03, 2020 | Chief Medical Officer | Other acquisition or disposition | Form 4 | -- | -- | 20 | |
| Jan 03, 2020 | Director, Chief Operating Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 13,973 | $9.18 | 345,195 | |
| Jan 03, 2020 | Director, Chairman & CEO | Other acquisition or disposition | Form 4 | -- | -- | 64,895 | |
| Jan 03, 2020 | Director, Chairman & CEO | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 19,994 | $9.18 | 939,290 | |
| Jan 03, 2020 | Chief Science Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 9,330 | $9.18 | 499,231 | |
| Jan 03, 2020 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 5,305 | $9.18 | 181,969 | |
| Jan 03, 2020 | Chief Legal Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 8,980 | $9.18 | 185,350 | |
| Jan 03, 2020 | Chief Legal Officer | Other acquisition or disposition | Form 4 | -- | -- | 15,000 | |
| Jan 02, 2020 | Chief Medical Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 6,633 | $9.55 | 182,889 | |
| Jan 02, 2020 | Chief Medical Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 61,601 | -- | 199,275 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.